title: Why we need guidelines for clinical trials in vasculitis and systemic lupus erythematosus.
authors.forename: Chetan
authors.initials: C
authors.lastname: Mukhtyar
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Boumpas
authors.forename: Caroline
authors.initials: C
authors.lastname: Gordon
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Gross
authors.forename: David
authors.initials: D
authors.lastname: Jayne
authors.forename: Raashid
authors.initials: R
authors.lastname: Luqmani
mesh_terms: D002986:Clinical Trials as Topic / Q000191:economics / Q000592:standards*; D017408:Guidelines as Topic; D017048:Health Care Costs; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D012107:Research Design / Q000592:standards; D016896:Treatment Outcome; D014657:Vasculitis / Q000188:drug therapy*